AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Cancer Biology & Medicine Article
PDF (147.8 KB)
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Editorial | Open Access

Hodgkin’s lymphoma: 2023 update on treatment

Sicong Zhang, Xianming Liu, Lanfang Li, Lihua Qiu, Zhengzi Qian, Shiyong Zhou, Xianhuo Wang ( ), Huilai Zhang ( )
Department of Lymphoma, Tianjin Medical University Cancer Institute & Hospital, National Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, National Clinical Research Center for Cancer, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, The Sino-US Center for Lymphoma and Leukemia Research, Tianjin 300060, China
Show Author Information

References

【1】
【1】
 
 
Crossref Google Scholar
Cancer Biology & Medicine
Volume 21 Issue 4,
April 2024
Pages 269-273
DOI: 10.20892/j.issn.2095-3941.2023.0427

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Cite this Report
Close
Close
Cite this article:
Zhang S, Liu X, Li L, et al. Hodgkin’s lymphoma: 2023 update on treatment. Cancer Biology & Medicine, 2024, 21(4): 269-273. https://doi.org/10.20892/j.issn.2095-3941.2023.0427

987

Views

207

Downloads

1

Crossref

2

Web of Science

2

Scopus
Received: 21 November 2023
Accepted: 08 December 2023
Published: 29 December 2023
©2024 The Authors.

Creative Commons Attribution-NonCommercial 4.0 International License